These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12828775)

  • 1. Importance of trial design in studies using high-dose intravenous immunoglobulin.
    Jolles S; Hughes J
    Br J Dermatol; 2003 Jun; 148(6):1284-5; author reply 1285-6. PubMed ID: 12828775
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.
    Jolles S; Sewell C; Webster D; Ryan A; Heelan B; Waite A; Rustin M
    Acta Derm Venereol; 2003; 83(6):433-7. PubMed ID: 14690338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.
    Jolles S; Hughes J; Rustin M
    J Am Acad Dermatol; 1999 Jan; 40(1):121-3. PubMed ID: 9922029
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose gammaglobulin treatment for atopic dermatitis.
    Kimata H
    Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.
    Jolles S; Hughes J; Rustin M
    Br J Dermatol; 2000 Mar; 142(3):551-4. PubMed ID: 10735971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases.
    Toledo F; Silvestre JF; Muñoz C
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1325-7. PubMed ID: 22050044
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.
    Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N
    Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202
    [No Abstract]   [Full Text] [Related]  

  • 9. Atopic prurigo nodularis responds to intravenous immunoglobulins.
    Feldmeyer L; Werner S; Kamarashev J; French LE; Hofbauer GF
    Br J Dermatol; 2012 Feb; 166(2):461-2. PubMed ID: 21910702
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.
    Paul C; Lahfa M; Bachelez H; Chevret S; Dubertret L
    Br J Dermatol; 2002 Sep; 147(3):518-22. PubMed ID: 12207594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulation in the treatment of atopic dermatitis].
    Jílek D; Král V; Duchková H; Richter J
    Cas Lek Cesk; 1998 Jun; 137(13):397-9. PubMed ID: 9748732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
    Noh G; Lee KY
    J Korean Med Sci; 1999 Feb; 14(1):63-8. PubMed ID: 10102526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of immunoglobulin (Ig) in peripheral neuropathies. Impact of Ig on remission rates: comparison of intravenous immunoglobulin and subcutaneous immunoglobulin.
    Yoon MS
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):25-6. PubMed ID: 25546750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ebm and future direction of allergen-specific immunotherapy for atopic dermatitis].
    Mihara S; Hide M
    Arerugi; 2008 May; 57(5):499-506. PubMed ID: 18520169
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting of Patient Global Assessments in Atopic Dermatitis Randomized Controlled Trials.
    Grinich EE; Pawlitschek T; Simpson EL
    Dermatitis; 2020; 31(1):e7-e9. PubMed ID: 31688131
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alopecia areata universalis and disseminated mollusca contagiosa in atopic dermatitis. Hair re-growth during treatment with interferon gamma--therapeutic effect or coincidence?].
    Hein U; Anegg B; Volc-Platzer B
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):441-4. PubMed ID: 15892847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. House dust mite reduction in the management of atopic dermatitis. A critically appraised topic.
    Garritsen FM; ter Haar NM; Spuls PI
    Br J Dermatol; 2013 Apr; 168(4):688-91. PubMed ID: 23528056
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system.
    Gendelman SR; Lang DM
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):555-61. PubMed ID: 24267368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.